EyeOnDrug aims to provide nanotechnology-based products and services, such as high-throughput screening strategies (HTS) for in vitro drug profiling, with applications in drug discovery research and nanoformulations development both in pharmaceutical and cosmeceutic areas. HTS assays will provide, in the early stages of development, a profiling of the candidate molecules/formulations giving an early awareness of potential unsuccessful drug candidates and potential difficulties in formulation, development process and safety that would otherwise increase time/cost, subsequent in vivo tests and also delay clinical appliance. Additionally, we aim to bestow solutions to the overall development process.